Empire Genomics was created in 2006 from research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The laboratory has a strong track record in the development of high throughput technologies to enable genome-wide analyses aimed at determining the underlying mechanisms for diseases. Having played a fundamental role in the Human Genome Project and created the foundational Bacterial Artificial Chromosomes which served as the basis for sequencing the genome, Empire’s lab developed significant expertise in genomic research. It is from this strong experiential base that we bring our capabilities, tools and techniques to support the research, clinical and drug discovery global community.
Realizing the possibility of where genomics tools will take medicine is not difficult to see, however for this potential to become reality will take genomic solutions which are robust and permit the high resolution detection of genomic aberrations and their corresponding correlations to underlying phenotypes. Traditionally the field has been plagued with immature technological tools with too much inconsistency, no customization and uncontrollable variability. Empire Genomics is excited to bring its expertise to bear on these challenges.
Empire Genomics is committed to working with the scientific community to bring the best in genomic technologies to bear on the complex systems biology questions that we collectively seek to answer. We will continually work to remove costly variation, inconsistency and the lack of reproducibility that has prevented the field from rapidly moving forward with discoveries.
